EUROPEAN JOURNAL OF NEUROLOGY, published by WILEY, stands as a leading platform for the dissemination of innovative research and clinical developments in the field of neurology. With a robust impact factor and prestigious rankings, including being positioned as Q1 in both Neurology and Clinical Neurology categories, the journal plays a pivotal role in shaping neurological sciences from 1994 to 2024. Its Scopus rank highlights its importance, being in the 88th percentile for clinical neurology and 87th percentile for neuroscience. Located in the United Kingdom, the journal thrives as a vital resource for researchers, clinicians, and students dedicated to improving neurological health outcomes. Although it does not offer Open Access, its subscription-based model ensures high-quality peer-reviewed articles are accessible to a global audience, reflecting the continuous pursuit of excellence in neurological research and patient care.

Welcome to Neurocritical Care, a leading journal dedicated to advancing the field of neurocritical care medicine. Published by HUMANA PRESS INC, this esteemed journal boasts a commendable impact, having secured its position in the top quartile (Q1) for both Critical Care and Intensive Care Medicine as well as Clinical Neurology in 2023. Aimed at healthcare professionals, researchers, and students, Neurocritical Care serves as a vital platform for disseminating cutting-edge research, comprehensive reviews, and clinical guidelines that enhance the understanding and management of critically ill neurological patients. With a focus on high-quality, peer-reviewed content, this journal plays a critical role in shaping clinical practice and improving patient outcomes in neurocritical settings. Spanning from 2004 to 2024, its rich archive will continue to support the academic community and foster innovation in this essential area of medicine.

CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.

INTERVENTIONAL NEURORADIOLOGY, published by SAGE PUBLICATIONS INC, is a key journal within the interdisciplinary fields of cardiology, neurology, and radiology, focusing on the latest advancements and clinical practices in neuroradiology. With an ISSN of 1591-0199 and an E-ISSN of 2385-2011, this journal has established itself as a vital resource since its inception in 1996, attracting contributions from leading experts worldwide. Currently categorized in the Q2 category for Cardiology and Cardiovascular Medicine and Radiology, and Q3 for Clinical Neurology as of 2023, INTERVENTIONAL NEURORADIOLOGY has gained recognition for its impactful research, reflected in its ranking within the Scopus metrics. Although not an open-access publication, its rigorous peer-reviewed articles provide indispensable knowledge that enhances the practice and understanding of interventional procedures. Researchers, clinicians, and students will find this journal a valuable avenue for insights into the evolving landscape of neuroradiological interventions, ultimately contributing to improved patient outcomes.

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

STROKE is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of neurology, cardiology, and specialized nursing. With an impressive impact factor and consistently ranked in the Q1 category across multiple disciplines—such as Advanced and Specialized Nursing, Cardiology, and Neurology—this journal serves as a crucial platform for researchers and healthcare professionals. It spans a rich historical context from 1970 to 2024, offering invaluable insights into stroke research and related cerebral vascular issues. The journal is committed to disseminating high-quality research that informs clinical practices and guides policy-making in public health. With a focus on empirical studies and clinical trials, STROKE stands as an essential resource for those invested in the complexities of neurological interventions and cardiovascular health. Ensure your access to this influential publication as it shapes the future of medical science and patient care.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, published by SAGE PUBLICATIONS INC, stands as a premier resource in the fields of Cardiology and Neurology, with a remarkable impact on our understanding of cerebral physiology since its inception in 1981. This esteemed journal, boasting a Q1 ranking in multiple categories, including Cardiology and Neurology, offers cutting-edge research articles that delve into the intricacies of cerebral blood flow and metabolic processes, essential for advancing both theoretical and clinical applications. With its significant placement in the Scopus rankings—12th in Neuroscience and 24th in Cardiovascular Medicine—this journal is pivotal for professionals, researchers, and students dedicated to the forefront of medical science. Although open access options are not currently available, the journal remains committed to disseminating high-quality research that addresses the challenges faced in cerebral health, ultimately guiding clinical practice and policy formulation. With an anticipated convergence extending through 2024, the JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM continues to be an indispensable asset within the scientific community.